Japanese company to expand operations and develop new molecular diagnostics platform with series D cash.
Atonarp's 'ATON-360' optical spectroscopy platform
Atonarp, a Tokyo-based company that sells optics-based molecular sensing equipment, says it has raised $50 million in a series D round of venture funding.
The Japanese firm, which also offers miniature mass spectrometers for industrial applications, plans to use the cash to expand operations and advance development of a new platform technology aimed at point-of-care diagnostics and cell biology.
Supported by Furukawa Electric and others alongside lead investor WRVI Capital, the latest round brings Atonarp’s total funding to $111 million.